Ascendis Pharma AS (ASND) — Cash Flow-to-Debt Ratio
Ascendis Pharma AS (ASND) has a Cash Flow-to-Debt Ratio of -0.01x as of March 2026, meaning its operating cash flow of $-7.85 Million could theoretically repay 0% of its total liabilities ($1.52 Billion) in one year. Explore Ascendis Pharma AS long-term investment allocation to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Ascendis Pharma AS Cash Flow-to-Debt Ratio (2012–2025)
Historical debt coverage capacity for Ascendis Pharma AS across 14 annual periods. Also explore Ascendis Pharma AS balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Ascendis Pharma AS (2012–2025)
Year-by-year debt coverage analysis for Ascendis Pharma AS. For market capitalisation and broader financial context, see ASND market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.04x | $51.77 Million | $1.46 Billion | ▲ +114.8% |
| 2024 | -0.24x | $-306.20 Million | $1.29 Billion | ▲ +50.5% |
| 2023 | -0.48x | $-467.36 Million | $971.28 Million | ▲ +19.8% |
| 2022 | -0.60x | $-495.70 Million | $826.39 Million | ▲ +71.1% |
| 2021 | -2.07x | $-417.65 Million | $201.29 Million | ▼ -7.8% |
| 2020 | -1.92x | $-271.55 Million | $141.08 Million | ▲ +12.9% |
| 2019 | -2.21x | $-175.94 Million | $79.62 Million | ▲ +38.0% |
| 2018 | -3.57x | $-138.80 Million | $38.92 Million | ▲ +10.9% |
| 2017 | -4.00x | $-95.10 Million | $23.77 Million | ▲ +10.5% |
| 2016 | -4.47x | $-60.18 Million | $13.46 Million | ▼ -17.7% |
| 2015 | -3.80x | $-43.47 Million | $11.45 Million | ▼ -165.4% |
| 2014 | -1.43x | $-18.40 Million | $12.86 Million | ▼ -562.6% |
| 2013 | 0.31x | $6.31 Million | $20.40 Million | ▲ +1231.5% |
| 2012 | -0.03x | $-652.00K | $23.85 Million | — |